Cargando…
Synergistic Anticancer Effect of a Combination of Berbamine and Arcyriaflavin A against Glioblastoma Stem-like Cells
Glioblastoma multiforme (GBM) is the most aggressive form of brain tumor. Relapse is frequent and rapid due to glioblastoma stem-like cells (GSCs) that induce tumor initiation, drug resistance, high cancer invasion, immune evasion, and recurrence. Therefore, suppression of GSCs is a powerful therape...
Autores principales: | Han, Jang Mi, Jung, Hye Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9699626/ https://www.ncbi.nlm.nih.gov/pubmed/36432068 http://dx.doi.org/10.3390/molecules27227968 |
Ejemplares similares
-
Discovery of a New CaMKII-Targeted Synthetic Lethal Therapy against Glioblastoma Stem-like Cells
por: Han, Jang Mi, et al.
Publicado: (2022) -
Synergistic Antitumor Effects of Berbamine and Paclitaxel through ROS/Akt Pathway in Glioma Cells
por: Jia, Feng, et al.
Publicado: (2017) -
Regulation of Cell-Signaling Pathways by Berbamine in Different Cancers
por: Farooqi, Ammad Ahmad, et al.
Publicado: (2022) -
Berbamine (BBM), a Natural STAT3 Inhibitor,
Synergistically Enhances the Antigrowth and Proapoptotic Effects of
Sorafenib on Hepatocellular Carcinoma Cells
por: Zhao, Weijia, et al.
Publicado: (2020) -
A Novel Berbamine Derivative Inhibits Cell Viability and Induces Apoptosis in Cancer Stem-Like Cells of Human Glioblastoma, via Up-Regulation of miRNA-4284 and JNK/AP-1 Signaling
por: Yang, Fan, et al.
Publicado: (2014)